Teladoc Health Inc reports results for the quarter ended September 30 - Earnings Summary

• Teladoc Health Inc TDOC.N reported a quarterly adjusted loss of 15 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -28 cents. The mean expectation of twenty one analysts for the quarter was for a loss of 21 cents per share. Wall Street expected results to range from -26 cents to -15 cents per share.

• Revenue fell 3.4% to $605.10 million from a year ago; analysts expected $588.48 million.

• Teladoc Health Inc's reported EPS for the quarter was a loss of 15 cents​.

• The company reported a quarterly loss of $26.93 million.

• Teladoc Health Inc shares had risen by 11.2% this quarter and lost 7.9% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 6.4% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy," 18 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is "buy."

• Wall Street's median 12-month price target for Teladoc Health Inc is $6.75, about 1.9% above its last closing price of $6.88

This summary was machine generated from LSEG data October 28 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)